Indian red scorpion envenoming


The clinical course and treatment outcome of scorpion envenoming in 293 children was studied in a hospital at Mahad in Raigad district of Maharastra. 111 (38%) children who reported 1–10 hours (mean 3.5 hours) after sting had hypertension, 87 (29.6%) with tachycardia reported within 1–24 hours (mean 6.7 hours) of being envenomed and 72 (24.5%) children developed acute pulmonary edema after 6–24 hours (mean 8 hours) of sting. Six victims were brought dead, while 17 (6%) died later owing to multiorgan failure with loss of consciousness and convulsions (who reported after 24 hours of sting). Early administration of prazosin (125–250 ug orally) improved the clinical symptoms. Morbidity and mortality due to scorpion envenoming depends upon time lapse between sting and administration of post synaptic α-1 blocker, prazosin hydrochloride.

This is a preview of subscription content, log in to check access.


  1. 1.

    Amitai Y, Mines Y, Aker M, Goitein K. Scorpion sting in children.Clin Pediatr 1984; 24: 136–140.

    Article  Google Scholar 

  2. 2.

    Waterman JA. Some notes on scorpion poisoning in Trinidad.Trans Roy Soc Trop Med Hyg 1938; 31: 607–624.

    Article  CAS  Google Scholar 

  3. 3.

    Amaral CFS, Derezende NA, Freire-maia L. Acute pulmonary oedema afterTitus serrulatus scorpion sting in children.Am J Cardiol 1992; 71: 242–245.

    Article  Google Scholar 

  4. 4.

    Sofer S, Shachak E, Slonin A, Gueron M. Myocardial injury without heart failure following envenomation by the scorpionLeiurus quniquestriatus in children.Toxicon 1991; 29: 382–385.

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Santhanakrishanan BK, Raju VB. Management of scorpion sting in children.J Trop Med Hyg 1974; 77: 136–139.

    Google Scholar 

  6. 6.

    Gaitonde BB, Jadhav SS, Bawaskar HS. Pulmonary oedema after scorpion sting.Lancet 1978; i: 445–446.

    Article  Google Scholar 

  7. 7.

    Mundle PM. Scorpion sting.Br Med J 1961; i: 1042.

    Google Scholar 

  8. 8.

    Rajarajeswari G, Sivaprakasam S, Viswanthan J. Morbidity and mortality pattern in scorpion sting: a review of 68 cases.J Ind Med Assoc 1979; 73: 123–126.

    CAS  Google Scholar 

  9. 9.

    Bawaskar HS. Scorpion sting and cardiovascular complications.Ind Heart J 1977; 29 (i): 228.

    CAS  Google Scholar 

  10. 10.

    Bawaskar HS, Bawaskar PH. Prazosin in management of cardiovascular menifestations so scorpion sting.Lancet 1986; i; 510–511.

    Article  Google Scholar 

  11. 11.

    Bawaskar HS. Diagnostic cardiac premonitory signs and symptoms of red scorpion sting.Lancet 1982; 552–54.

  12. 12.

    Murthy KPR, Billimoria FR, Khopkar M, Dave KN. Acute hyperglycemia and hyperkalaemia in acute myocarditis produced by scorpion (Buthus tamulus) venom injection in dogs.Ind Heart J 1986; 38 (1): 71–74.

    CAS  Google Scholar 

  13. 13.

    Rao P, Premlatha BK, Bhatt V, Harinath PSRK. Cardiac and behavioural effects of scorpion venom in experimental animals.Ind Pediatr 1969; 6 (3): 95–101.

    CAS  Google Scholar 

  14. 14.

    Murthy KRK, Vakil AE. Elevation of plasma angiotensin levels in dogs by Indian red scorpions (Bothus tamulus) venom and its reversal by administration of insulin + tolazoline.Ind J Med Res 1988; 88: 376–379.

    CAS  Google Scholar 

  15. 15.

    Freire-mai L, Campos JA. Pathophysiology and treatment of scorpion poisoning in ownby CL de Natural toxins.LCGV 1989; 139–159.

  16. 16.

    Sofer S, Shahak E, Gueron M. Scorpion envenomation and antivenin therapy.J Pediatr 1994; 124: 973–978.

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Abroug E, Ayari M, Nouriras Set al. Assessment of left ventricular function in severe scorpion envenomation: combined hemodynamic and echodoppler study.Intensive Care Med 1995; 21: 629–635.

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Ramchandran LK, Agarwal OP, Achuthan KEet al. Fractionation and biological activities of venom of the Indian scorpionButhus tamulus andHeterometrus bengalensis.Ind Bioch Biophysic 1986; 23: 335–338.

    Google Scholar 

  19. 19.

    Bawaskar HS, Bawaskar PH. Consecutive stings by red scorpions evokes severe cardiovascular manifestations in the first, but not in the second victim: a clinical observation.J Trop Med Hyg 1991; 94: 231–233.

    PubMed  CAS  Google Scholar 

  20. 20.

    Amaral CFS, Lopes JA, Magalhaes RA, De Rezende NA. Electrocardiographic enzymatic and echocardiographic evidences of myocardial damage afterTityus semrulatus scorpion poisoning.Am J Cardiol 1991; 67: 654–656.

    Article  Google Scholar 

  21. 21.

    Gueron M, Margulus G, Sofer S. Echocardiographical radionuclide angiogrpahic observations following scorpion envenomation byLeiurus quinguestriatus.Toxicon 1990; 28: 1005–1009.

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    Bawaskar HS, Bawaskar PH. Stings by red scorpion (Buthus tamulus) in Maharashtra state, India: A clinical study.Trans Roy Soc Trop Med Hyg 1989; 83: 856–860.

    Article  Google Scholar 

  23. 23.

    Choudhury LK, Ganguly DK. Some cardiovascular effects of crude scorpion venom.Ind J Med Res 1978; 68: 15–18.

    Google Scholar 

  24. 24.

    Gueron M, Stern J, Cohen W. Severe myocardial damage and heart failure in scorpion sting.Am J Cardiol 1967; 19: 719–726.

    PubMed  Article  CAS  Google Scholar 

  25. 25.

    Dudin AA, Cousson AR, Thalji A, Juaben I, Libden AB. Scorpion sting in children in the Jerusalem area. A review of 54 cases.Ann Trop Pediat 1991; 11: 217–223.

    CAS  Google Scholar 

  26. 26.

    El Amin EO, Elidrissay A, Hamid HS, Sultan OM, Safar RA. Scorpion sting. A management problem.Ann Trop Pediatr 1991; 11: 143–148.

    Google Scholar 

  27. 27.

    Dehesa-Davila M. Epidemiological characteristics of scorpion sting in Leon, Gunjuato, Mexico.Toxicon 1989; 27: 281–286.

    PubMed  Article  CAS  Google Scholar 

  28. 28.

    Zlotkin E, Shulov AS. Recent studies on the mode of action of scorpion neurotoxins: A review.Toxicon 1969; 7: 217–221.

    PubMed  Article  CAS  Google Scholar 

  29. 29.

    Strong PN. Potassium channel.Toxin Pharmacol Ther 1990; 46: 137–162.

    Article  CAS  Google Scholar 

  30. 30.

    Brewster BS, Strong PN. Naturally occuring potassium channel blockers in western AG, Hamilten TG eds.Potassium channel modulator. 1992; 272–303.

  31. 31.

    Sofer S. Scorpion envenomation.Int Care Med 1995; 21: 626–628.

    Article  CAS  Google Scholar 

  32. 32.

    Kumar EB, Soomro RS, Handani AA, Shimy NE. Scorpion venom cardiomyopathy.Am Heart J 1992; 123: 725–729.

    PubMed  Article  CAS  Google Scholar 

  33. 33.

    Yarom R. Scorpion venom: a tutorial review of its effects in men and experimental animals.Clin Toxicol 1970; 3: 561–569.

    PubMed  CAS  Google Scholar 

  34. 34.

    Gueron M, Yarom K. Cardiovascular manifestations of severe scorpion sting.Chest 1970; 57: 156–162.

    PubMed  Article  CAS  Google Scholar 

  35. 35.

    Bawaskar HS, Bawaskar PH. Cardiovascular manifestation of severe scorpion sting in children: Review of 34 children.Ann Trop Pediatr 1991; 11: 381–387.

    CAS  Google Scholar 

  36. 36.

    Gueron M, Ovshcher I. What is the treatment of cardiovascular manifestations of scorpion envenomation?Toxicon 1987; 25 125–130.

    Article  Google Scholar 

  37. 37.

    Bawaskar HS, Bawaskar PH. Role of atropine in management of cardiovascular manifestations of scorpion envenoming in humans.J Trop Med Hyg 1992; 95: 30–35.

    PubMed  CAS  Google Scholar 

  38. 38.

    Karnad DR, Deo AM, Apte N, Lohe AS. Captopril for correcting diuretic induced hypotension in pulmonary oedema after scorpion sting.Brit Med J 1989; 298: 1430–1431.

    PubMed  CAS  Article  Google Scholar 

  39. 39.

    Bawaskar HS, Bawaskar PH. Vasodilators: Scorpion envenoming and the heart.Toxicon 1994; 32: 1031–1040.

    PubMed  Article  CAS  Google Scholar 

  40. 40.

    Raab W. Key position of catecholamines in functional and degenerative cardiovascular pathology.Am J Cardiol 1960; 5: 571–578.

    PubMed  Article  CAS  Google Scholar 

  41. 41.

    Sofer S, Gueron M. Vasodilators and hypertensive encephalopathy following scorpion envenomation in children.Chest 1990; 97: 118–120.

    PubMed  Article  CAS  Google Scholar 

  42. 42.

    Frohlich ED, Apatenin C, Chobunianet al. The heart in hypertension.N Eng J Med 1992; 327: 998–1005.

    CAS  Article  Google Scholar 

  43. 43.

    Freieire JS, Underbil LH. Muscarinic receptors subtypephysiology and clinical complications.N Eng J Med 1969; 321: 1022–1028.

    Google Scholar 

  44. 44.

    Cody RJ, Haas GJ, Binkley PFet al. Plasma endothelin correlates with the extent of pulmonary oedema hypertension in patients with chronic congestive heart failure.Circulation 1992; 85: 504–509.

    PubMed  CAS  Google Scholar 

  45. 45.

    Vallance P, Cooler J. Biology and clinical relevance of nitric oxide.Br Med J 1990; 309: 453–457.

    Google Scholar 

  46. 46.

    Lee JC, Spoonenburg DP. Role of alpha adrenoceptors in norepinephrine induced cardiomyopathy.Am J Pathology 1985; 121 316–317.

    CAS  Google Scholar 

  47. 47.

    Siman SM, Downing SE. Coronary vasoconstriction and catecholamine cardiomyopathy.Am Heart J 1985; 109: 297–304.

    Article  Google Scholar 

  48. 48.

    Kurien VA, Oliver LMF. A metabolic cause of arrhythmias during myocardial hypoxia.Lancet 1994; 242: 155–128.

    Google Scholar 

  49. 49.

    Oliver MF, Opie LH. Effects of glucose and fatty acid on myocardial ischemia and arrythmias.Lancet 1994; 343: 155–158.

    PubMed  Article  CAS  Google Scholar 

  50. 50.

    Murthy KRK. Insulin reversal haemodynamic changes and pulmonary oedema in children stung by the Indian red scorpionMesobuthus tamulus conanesce pocock.Ann Trop Med Parasitcal 1991; 85: 651–657.

    CAS  Google Scholar 

  51. 51.

    Medical research council. Clinical trial of potassium, glucose, insulin (PGI) Treatment in myocardial infarction.Lancet 1968; 11: 1055–1060.

    Google Scholar 

  52. 52.

    Cubeddu LX. New alpha-1 adrenergic receptor antagonists for the treatment of hypertension role of vascular alpha receptors in the control of peripheral resistance.Am Heart J 1988; 116: 133–162.

    PubMed  Article  CAS  Google Scholar 

  53. 53.

    Garrison JC, Peach NJ, Kall SW, Nies AS, Taylor P eds.Renin and angiotensin in the pharmacological basis of therapeutics. 8th edn. PP 749–763. Gilman AG, New York Pergaman press 1990.

    Google Scholar 

  54. 54.

    Ismail M. The scorpion envenoming syndrome.Toxicon 1995; 33: 825–858.

    PubMed  Article  CAS  Google Scholar 

  55. 55.

    Gueron M, Margulis G, Ilia R, Sofer S. The management of scorpion envenomation.Toxicon 1993; 31: 1071–1076.

    PubMed  Article  CAS  Google Scholar 

  56. 56.

    Bawaskar HS, Bawaskar PH. Treatment of cardiovascular manifestation sof human scorpion envenoming. Is serotherapy essential?J Trop Med Hyg 1991; 94: 156–158.

    PubMed  CAS  Google Scholar 

  57. 57.

    Ismail M. Serotherapy of the scorpion envenoming syndrome is irrationally convicted without trial.Toxicon 1993; 31: 1077–1083.

    Article  Google Scholar 

  58. 58.

    Ismail M. The treatment of the scorpion envenoming syndrome. The Saudi experience with serotherapy.Toxicon 1994; 32: 1019–1026.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to H. S. Bawaskar MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bawaskar, H.S., Bawaskar, P.H. Indian red scorpion envenoming. Indian J Pediatr 65, 383–391 (1998).

Download citation

Key words

  • Scorpion
  • Pulmonary edema
  • Prazosin